Insider Transactions in Q4 2024 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.34%
|
$165,000
$55.43 P/Share
|
|
Dec 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-1.57%
|
$3,300,000
$55.74 P/Share
|
|
Dec 10
2024
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.3%
|
$220,000
$55.0 P/Share
|
|
Dec 01
2024
|
Karen Silva Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,215
+50.0%
|
-
|
|
Nov 20
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.67%
|
$150,000
$50.83 P/Share
|
|
Nov 18
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-2.21%
|
$3,060,000
$51.06 P/Share
|
|
Oct 29
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.67%
|
$150,000
$50.0 P/Share
|
|
Oct 29
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-3.38%
|
$2,000,000
$50.05 P/Share
|
|
Oct 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-3.16%
|
$1,800,000
$45.17 P/Share
|
|
Oct 01
2024
|
Kevin T Strange Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,041
-0.36%
|
$41,640
$40.63 P/Share
|
|
Oct 01
2024
|
Kevin T Strange Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,695
+10.53%
|
-
|
|
Oct 01
2024
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,222
-0.23%
|
$168,880
$40.63 P/Share
|
|
Oct 01
2024
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,120
-0.17%
|
$84,800
$40.63 P/Share
|
|
Oct 01
2024
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-0.16%
|
$82,520
$40.63 P/Share
|
|
Oct 01
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,067
-0.29%
|
$82,680
$40.63 P/Share
|